A randomized, double blind trial of prophylactic fibrinogen to reduce bleeding in cardiac surgery;Estudo randÔmico e duplo-cego de profilaxia com fibrinogênio para reduzir o sangramento em cirurgia cardíaca

Revista Brasileira de Anestesiologia

Volumn 64, Issue 4, 2014, Pages 253-257

  Sadeghi, Mostafa ^a   Atefyekta, Reza ^a   Azimaraghi, Omid ^a   Marashi, Seyed Mojtaba ^a   Aghajani, Yasaman ^a   Ghadimi, Fatemeh ^a   Spahn, Donat R ^b   Movafegh, Ali ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Bleeding; Blood transfusion; Cardiac surgery; Cardiopulmonary bypass; Hemostasis

Indexed keywords

FIBRINOGEN CONCENTRATE; HEMOGLOBIN; PLACEBO;

ARTICLE; BLOOD VOLUME; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ERYTHROCYTE TRANSFUSION; HEART SURGERY; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTERNATIONAL NORMALIZED RATIO; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL;

EID: 84903709483     PISSN: 00347094     EISSN: 1806907X     Source Type: Journal    
DOI: 10.1016/j.bjan.2013.10.008     Document Type: Article

References (16)

1. Zacharias A., Habib R.H. Factors predisposing to median sternotomy complications. Deep vs superficial infection. Chest 1996, 110:1173-1178.
2. Unsworth-White M.J., Herriot A., Valencia O., et al. Resternotomy for bleeding after cardiac operation: a marker for increased morbidity and mortality. Ann Thorac Surg 1995, 59:664-667.
3. Paparella D., Brister S.J., Buchanan M.R. Coagulation disorders of cardiopulmonary bypass: a review. Intensive Care Med 2004, 30:1873-1881.
4. Wahba A., Rothe G., Lodes H., et al. Predictors of blood loss after coronary artery bypass grafting. J Cardiothorac Vasc Anesth 1997, 11:824-827.
5. Furie B., Furie B.C. Mechanisms of thrombus formation. N Engl J Med 2008, 28:938-949.
6. Mosesson M.W. Fibrinogen and fibrin structure and functions. J Thromb Haemost 2005, 3:1894-1904.
7. Standeven K.F., Ariens R.A., Grant P.J. The molecular physiology and pathology of fibrin structure/function. Blood Rev 2005, 19:275-288.
8. Aljassim O., Karlsson M., Wiklund L., et al. Inflammatory response and platelet activation after off-pump coronary artery bypass surgery. Scand Cardiovasc J 2006, 40:43-48.
9. Hiippala S.T., Myllyla G.J., Vahtera E.M. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 1995, 81:360-365.
10. Pavie A., Szefner J., Leger P., et al. Preventing, minimizing, and managing postoperative bleeding. Ann Thorac Surg 1999, 68:705-710.
11. Despotis G.J., Skubas N.J., Goodnough L.T. Optimal management of bleeding and transfusion in patients undergoing cardiac surgery. Semin Thorac Cardiovasc Surg 1999, 11:84-104.
12. Karlsson M., Ternström L., Hyllner M., Baghaei F., Nilsson S., Jeppsson A. Plasma fibrinogen level, bleeding, and transfusions after on-pump coronary artery bypass grafting surgery: a prospective observational study. Transfusion (Paris) 2008, 48:2152-2158.
13. Karlsson M., Ternström L., Hyllner M., et al. Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomized pilot study. Thromb Haemost 2009, 102:137-144.
14. Blome M., Isgro F., Kiessling A., et al. Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and post-operative bleeding in cardiopulmonary bypass surgery. Thromb Haemost 2005, 93:1101-1107.
15. Rahe-Mayer N., Pichlmaier M., Haverich A., et al. Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study. Br J Anaesth 2009, 102:785-792.
16. Solomon C., Pichlmaier U., Schoechl H., et al. Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery. Br J Anaesth 2010, 104:555-562.